Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 11,430 shares at $123.58 ($1.4M) on 2026-07-01, disclosed to the SEC on 2026-07-06.
Scheduled sale ($1.4M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |
| NUVL | SELL | 2026-01-07 | $721K | — | Filing → |